Covaris enters co-marketing partnership with Illumina for DNA shearing technologies

Covaris Inc. (a privately-held MA based company) today announced that it has signed a co-marketing agreement with Illumina, Inc. (Nasdaq: ILMN) making Covaris DNA shearing technologies the recommended method of shearing with Illumina next-generation sequencing product lines, including HiSeq, HiScanSQ, and Genome Analyzer. In addition, the proprietary Covaris process enables higher recoveries for nucleic acid extraction, tissue homogenization, chromatin shearing, protein digestion, and cell lysis. The highly controlled Covaris technology is isothermal and non-contact, ensuring molecular stability throughout the sample preparation process.  Important for next-generation genetic analysis, the Covaris system allows customers to rapidly and precisely scale up sample processing capability. The Illumina-Covaris partnership will bring industry leading next-generation DNA shearing performance to Illumina's sequencing customers.  

Source:

Covaris, Inc.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Illumina, Inc.. (2024, July 05). Covaris enters co-marketing partnership with Illumina for DNA shearing technologies. News-Medical. Retrieved on October 31, 2024 from https://www.news-medical.net/news/20100929/Covaris-enters-co-marketing-partnership-with-Illumina-for-DNA-shearing-technologies.aspx.

  • MLA

    Illumina, Inc.. "Covaris enters co-marketing partnership with Illumina for DNA shearing technologies". News-Medical. 31 October 2024. <https://www.news-medical.net/news/20100929/Covaris-enters-co-marketing-partnership-with-Illumina-for-DNA-shearing-technologies.aspx>.

  • Chicago

    Illumina, Inc.. "Covaris enters co-marketing partnership with Illumina for DNA shearing technologies". News-Medical. https://www.news-medical.net/news/20100929/Covaris-enters-co-marketing-partnership-with-Illumina-for-DNA-shearing-technologies.aspx. (accessed October 31, 2024).

  • Harvard

    Illumina, Inc.. 2024. Covaris enters co-marketing partnership with Illumina for DNA shearing technologies. News-Medical, viewed 31 October 2024, https://www.news-medical.net/news/20100929/Covaris-enters-co-marketing-partnership-with-Illumina-for-DNA-shearing-technologies.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Illumina donates more than 95,000 human genetic variants to ClinVar database